Generative AI specialist DeepLife SAS has raises US$10m in a Series A financing led by YZR Capital and Relyens Innovation Santé with participation from Beiersdorf Venture Capital, Prunay Group, and existing investors.
https://european-biotechnology.com/wp-content/uploads/2024/12/deeplife-team.webp470780Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-12-17 09:09:562024-12-18 11:51:12DeepLife raises US$10m in Series A financing